Literature DB >> 21810973

Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms.

Chiara Elena, Elisa Rumi, Monica Portolan, Matteo G Della Porta, Cristiana Pascutto, Francesco Passamonti.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21810973      PMCID： PMC3148920          DOI： 10.3324/haematol.2011.047803

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Accelerated telomere length shortening in granulocytes: a diagnostic marker for myeloproliferative diseases.

Authors:  Yasushi Terasaki; Hirokazu Okumura; Shigeki Ohtake; Shinji Nakao
Journal:  Exp Hematol       Date:  2002-12       Impact factor: 3.084

2.  Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms.

Authors:  Emmanouil Spanoudakis; Ioanna Bazdiara; Despoina Pantelidou; Ioannis Kotsianidis; Vasilios Papadopoulos; Dimitrios Margaritis; George Xanthopoulidis; Eleftherios Moustakidis; Stamatia Mantzourani; George Bourikas; Costas Tsatalas
Journal:  Leuk Res       Date:  2010-09-09       Impact factor: 3.156

3.  Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

Authors:  Francesco Passamonti; Elisa Rumi; Daniela Pietra; Matteo G Della Porta; Emanuela Boveri; Cristiana Pascutto; Laura Vanelli; Luca Arcaini; Sara Burcheri; Luca Malcovati; Mario Lazzarino; Mario Cazzola
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

4.  Clonal granulocytes in polycythaemia vera and essential thrombocythaemia have shortened telomeres.

Authors:  Anna Maria Ferraris; Natalija Pujic; Rosa Mangerini; Davide Rapezzi; Andrea Gallamini; Omar Racchi; Salvatore Casciaro; Gian Franco Gaetani
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

5.  Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms.

Authors:  Daniela Pietra; Angela Brisci; Elisa Rumi; Sabrina Boggi; Chiara Elena; Alessandro Pietrelli; Roberta Bordoni; Maurizio Ferrari; Francesco Passamonti; Gianluca De Bellis; Laura Cremonesi; Mario Cazzola
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

6.  High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a.

Authors:  Jean-Jacques Kiladjian; Bruno Cassinat; Pascal Turlure; Nathalie Cambier; Murielle Roussel; Sylvia Bellucci; Marie-Laurence Menot; Gerald Massonnet; Jean-Luc Dutel; Kamel Ghomari; Philippe Rousselot; Marie-Jose Grange; Yasmina Chait; William Vainchenker; Nathalie Parquet; Lina Abdelkader-Aljassem; Jean-François Bernard; Jean-Didier Rain; Sylvie Chevret; Christine Chomienne; Pierre Fenaux
Journal:  Blood       Date:  2006-05-18       Impact factor: 22.113

7.  A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.

Authors:  F Passamonti; E Rumi; D Pietra; C Elena; E Boveri; L Arcaini; E Roncoroni; C Astori; M Merli; S Boggi; C Pascutto; M Lazzarino; M Cazzola
Journal:  Leukemia       Date:  2010-07-15       Impact factor: 11.528

Review 8.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

Review 9.  JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations.

Authors:  A Pardanani; A M Vannucchi; F Passamonti; F Cervantes; T Barbui; A Tefferi
Journal:  Leukemia       Date:  2010-11-16       Impact factor: 11.528

10.  Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood.

Authors:  N Rufer; T H Brümmendorf; S Kolvraa; C Bischoff; K Christensen; L Wadsworth; M Schulzer; P M Lansdorp
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307
View more
  4 in total

1.  Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms.

Authors:  Jenny Dahlström; Xiaolu Zhang; Mehran Ghaderi; Malin Hultcrantz; Magnus Björkholm; Dawei Xu
Journal:  Haematologica       Date:  2015-07-16       Impact factor: 9.941

2.  Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations.

Authors:  Samah Alimam; Donal P McLornan; Jie Jiang; Deepti Radia; Ghulam J Mufti; Claire N Harrison
Journal:  Haematologica       Date:  2017-11-30       Impact factor: 9.941

3.  TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.

Authors:  Jenny Dahlström; Tiantian Liu; Xiaotian Yuan; Leonie Saft; Mehran Ghaderi; Ya Bin Wei; Catharina Lavebratt; Ping Li; Chengyun Zheng; Magnus Björkholm; Dawei Xu
Journal:  Ann Hematol       Date:  2016-08-25       Impact factor: 3.673

4.  Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms.

Authors:  Matteo Giaccherini; Angelica Macauda; Nicola Sgherza; Juan Sainz; Federica Gemignani; Josè Manuel Sanchez Maldonado; Manuel Jurado; Francesca Tavano; Grzegorz Mazur; Andrés Jerez; Joanna Góra-Tybor; Aleksandra Gołos; Francisca Hernández Mohedo; Joaquin Martinez Lopez; Judit Várkonyi; Raffaele Spadano; Aleksandra Butrym; Federico Canzian; Daniele Campa
Journal:  Blood Cancer J       Date:  2020-09-01       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.